Sometimes, the medication may not work for you, or you may not be able to tolerate the full dose due to side effects, in which case, your practitioner will provide additional options or change the protocol to better suit your individual needs
Recommended Starting Dose of Retatrutide Phase 2 trial protocols typically initiated retatrutide at 2 mg once weekly via subcutaneous injection, allowing gradual physiological adaptation before dose escalation
Annu Rev Nutr 2007;27:179-92.ArticlePubMed 49
Conclusion Semaglutide gives favorable options for users who are struggling with obesity and want to reduce weight loss, specifically those who have not gotten enough results from other methods
References For further exploration into the science behind BPC-157 and its therapeutic applications, we invite you to delve into the following research studies: Link to study on gastrointestinal healing Link to study on wound healing Link to study on bone repair Link to study on neurological healing Link to study on anti-inflammatory effects Link to study on eye healing Link to study on antidepressant effects Link to study on tissue repair Link to study on dental treatments Link to study on antioxidant properties For more information or to explore how BPC-157 can support your health journey, contact us at Axon Integrative Health
If you want to understand how to move past this phase, see How to Break a Weight-Loss Plateau with Tirzepatide (Mounjaro, Zepbound)